Lundbeck Antipsychotic Sertindole Suspended From U.K. Market

Lundbeck's antipsychotic sertindole has been suspended from the U.K. market "due to concerns about reports of cardiac arrhythmias and sudden cardiac arrest," the U.K. Committee for the Safety of Medicines told prescribers Dec. 2.

More from Archive

More from Pink Sheet